The use of Indium-111-Labeled Platelets in the Management of Renal Transplant Patients

  • Helmut F. Sinzinger
  • Christian W. Leithner
Part of the NATO ASI Series book series (NSSA, volume 88)


The endothelium of arteries, capillaries, and veins of transplanted organs represents a frontier between the transplanted organ and the recipient. Its integrity depends on immunological considerations. In a recent publication, Frampton and coworkers (1) stated, “The more acute the rejection, the more profound the platelet involvement.”


Acute Rejection Renal Allograft Chronic Rejection Platelet Deposition Hyperacute Rejection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    G. Frampton, A. Parbtani, D. Marchesi, P. Duffus, M. Livio, G. Remuzzi, and J. S. Cameron, In vivo platelet activation with in vitro hyperaggregability to arachidonic acid in renal allograft recipients, Kidney Int 23:506.Google Scholar
  2. 2.
    H. Gewurz, D. S. Clark, J. Finstad, W. D. Kelly, R. L. Varco, R. A. Good, and A. E. Gabrielsen, Role of the complement system in graft rejection in experimental animals and man, Ann NY Acad Sci 129: 673 (1966).CrossRefGoogle Scholar
  3. 3.
    M. Kux, H. J. Boehmig, H. Amemiya, M. Torisu, T. Yokayama, B. Launois, M. Popovtzer, C. B. Wilson, F. J. Dixon, T. E. Starzl, Modification of hyperacute canine renal homograft rejection by the intra-arterial infusion of citrate, Surgery 70: 103 (1971).PubMedGoogle Scholar
  4. 4.
    A. Schilling, W. Land, E. Pratschkle, K. Pielsticker, W. Brendel, Dominant role of complement in the hyperacute xenograft rejection reaction, Surg Gyn Obstet 142: 29 (1976).Google Scholar
  5. 5.
    C. Leithner, H. Piza-Katzer, P. Kruzik, M. Winter, H. Sinzinger, W. R. Mayr, H. Stachlberger, Hyperakute Nierentransplantat-Abstbung: Rasterelektronenmikroskopie der intrarenalen Arterien, VASA 9: 137.Google Scholar
  6. 6.
    C. Leithner, H. Piza-Katzer, P. Kruzik, M. Winter, W. R. Mayr, H. Stachelberger, H. Sinzinger, A study of hyperacute rejection of renal transplants using scanning electron microscopy, Dialysis and Transplantation 10: 336 (1981).Google Scholar
  7. 7.
    G. J. Busch, A. C. P. Martins, N. K. Hollenberg, R. E. Wilson, R. W. Colman, A primate model of hyperacute renal allograft rejection, Am J Pathol 79: 31 (1975).PubMedGoogle Scholar
  8. 8.
    R. W. Colman, W. E. Braun, G. J. Busch, G. J. Dammin, J. P. Merrill, Coagulation studies in the hyperacute and other forms of renal-allograft rejection, New Engl J Med 281: 675 (1969).CrossRefGoogle Scholar
  9. 9.
    J. C. Rosenberg, R. J. Broersma, G. Bullemer, E. F. Mammen, R. Lenaghan, and B. F. Rosenberg, Relationship of platelets, blood, coagulation and fibrinolysis to hyperacute rejection of renal xenografts, Transplantation 8: 152 (1969).PubMedCrossRefGoogle Scholar
  10. 10.
    H. M. Sharma, S. Moore, H. W. Merrick, M. R. Smith, Platelets in early hyperacute allograft rejection in kidneys and their modification by sulfinpyrazone (anturan) therapy, Am J Pathol 66: 445 (1972).PubMedGoogle Scholar
  11. 11.
    G. M. Williams, H. J. Lee, R. F. Weymouth, W. R. Harlan, K. R. Holden, C. M. Stanley, G. A. Millington, D. M. Hume, Studies in hyperacute and chronic renal homograft rejection in man, Surgery 62: 204 (1967).Google Scholar
  12. 12.
    C. Grossklaus, B. Damerau, E. Lemgo, W. Voght, Induction of platelet aggregation by the complement-derived peptides C3a and C5a. Naunyn Schmiedebergs Arch Pharmacol 295: 71 (1976).PubMedCrossRefGoogle Scholar
  13. 13.
    T. R. Kohler, and N. L. Tilney, Microangiopathic hemolytic anemia associated with hyperacute rejection of a kidney allograft, Transplant Proc 14: 444 (1982).PubMedGoogle Scholar
  14. 14.
    G. J. Busch, E. S. Reynolds, E. G. Galvanek, W. E. Braun, G. J. Dammin, Human renal allografts. The role of vascular injury in early graft failure, Medicine 50: 29 (1971).PubMedCrossRefGoogle Scholar
  15. 15.
    P. Kincaid-Smith, Histological diagnosis of rejection of renal homografts in man, Lancet 11: 849 (1967).CrossRefGoogle Scholar
  16. 16.
    M. Lagarde, P. Bericaud, M. Burtin, M. Dechavanne, Refractoriness of diabetic platelets to inhibitory prostaglandins, Prostaglandins Med 7: 341 (1981).PubMedCrossRefGoogle Scholar
  17. 17.
    R. Lowenhaupt and P. Nathan, Platelet accumulation observed by electron microscopy in the early phase of rena allotransplant rejection, Nature 220: 822 (1968).PubMedCrossRefGoogle Scholar
  18. 18.
    R. Lowenhaupt and P. Nathan, The participation of platelets in the rejection of dog kidney allotransplants: hematologic and electron microscopic studies, Transplant Proc 1: 305 (1969).PubMedGoogle Scholar
  19. 19.
    K. A. Porter, J. B. Dossetor, T. L. Marchiorio, W. S. Peart, J. M. Rendall, T. E. Starzl, P. I. Terasaki, Human renal transplants. I. Glomerular changes, Lab Invest 16: 153 (1967).PubMedGoogle Scholar
  20. 20.
    G. J. Cerilli, J. E. Holliday, I. C. Lee, Antivascular endothelium antibody in renal transplantation, Surg Forum 26: 341 (1975).PubMedGoogle Scholar
  21. 21.
    L. C. Paul, L. A. Van Es, J. J. Van Rood, A. Van Leeuwen, G. Brutel de la Riviere, J. DeGraeff, Antibodies directed against antigens of the endothelium of pertubular capillaries in patients with rejecting renal allograft, Transplantation 27: 175 (1979).PubMedCrossRefGoogle Scholar
  22. 22.
    F. H. J. Claas, L. C. Paul, L. A. Van Es, J. J. Van Rood, Antibodies against donor antigen on endothelial cells and monocytes in eluates of rejected kidney allografts, Tissue Antigens 15: 19 (1980).PubMedCrossRefGoogle Scholar
  23. 23.
    G. F. J. Hendriks, G. M. T. Schreuder, F. H. J. Claas, J. D’Amoro, G. G. Persijn, B. Cohen, J. J. Van Rood, HLA-DRw6 and renal allograft ejection, Br Med J 286: 85 (1982).CrossRefGoogle Scholar
  24. 24.
    G. F. J. Hendriks, F. H. J. Claas, G. G. Persijn, M. D. Witvliet, W. Baldwin, and J. J. Van Rood, HLA-DRw6-positive recipients are high responder inrenal transplantation, Transplant Proc 15: 1136 (1983).Google Scholar
  25. 25.
    Y. M. Ooi, B. S. Ooi, E. H. Vallota, M. R. First, V. E. Pollak, Circulating immune complexes after renal transplantation. Correlation of increased I-125-Clq binding activity with acute rejection characterized by any fibrin deposition in the kidney, J Clin Invest 60: 611 (1977).PubMedCrossRefGoogle Scholar
  26. 26.
    T. Palosuo, K. Kano, S. Anthone, R. Gerbasi, and F. Milgrom, Circulating immune complexes after kidney transplantation, Transplantation 21: 312 (1976).PubMedCrossRefGoogle Scholar
  27. 27.
    W. J. Dempster, C. V. Harrison, and R. Shackman, Rejection processes in human homotransplantated kidneys, Br Med J 2: 969–976 (1964).PubMedCrossRefGoogle Scholar
  28. 28.
    G. Dunea, J. B. Hazard, W. J. Koff, Vascular changes in renal homografts, JAMA 190: 199 (1964).Google Scholar
  29. 29.
    D. M. Hume, J. P. Merril, B. F. Miller, C. W. Thron, Experiences with renal homotransplantation in the human: report of nine cases, J Clin Invest 34: 327 (1955).PubMedCrossRefGoogle Scholar
  30. 30.
    P. Kincaid-Smith, Vascular changes in homotransplants, Br Med J 1: 178 (1964).CrossRefGoogle Scholar
  31. 31.
    J. J. Trentin, The arterial obliterative lesions of human renal homografts, Ann NY Acad Sci 129: 654 (1966).CrossRefGoogle Scholar
  32. 32.
    K. A. Porter, K. Owen, J. F. Mowbray, W. B. Thomson, J. R. Kenyon, W. S. Peart, Obliterative vascular changes in four human kidney homotransplants, Br Med J 2: 639 (1963).PubMedCrossRefGoogle Scholar
  33. 33.
    P. Kincaid-Smith, Modification of the vascular lesions of rejection in cadaveric renal allografts by dipyridamole and anti-coagulants, Lancet 11: 920 (1969).CrossRefGoogle Scholar
  34. 34.
    O. Jonasson, H. J. Winn, M. H. Flax, P. S. Russell, Renal biopsies in long-term survivors of renal transplantation: immunofluorescent studies, Transplantation 5: 859 (1967).PubMedCrossRefGoogle Scholar
  35. 35.
    T. X. O’Connel and J. F. Mowbray Arterial intimai thickening produced by alloantibody and xenoantibody, Transplantation 15: 262 (1973).CrossRefGoogle Scholar
  36. 36.
    C. Leithner, H. Sinzinger, P. Angelberger, G. Syre, Indium-111-labeled platelets in chronic kidney transplant rejection, Lancet 11: 213 (1980).CrossRefGoogle Scholar
  37. 37.
    C. Leithner, H. Sinzinger, M. Schwarz, Treatment of chronic kidney transplant rejection with prostacyclin-reduction of platelet deposition in the transplant; prolongation of platelet survival and improvement of transplant function, Prostaglandins 22: 783 (1981).PubMedCrossRefGoogle Scholar
  38. 38.
    C. Leithner, H. Sinzinger, M. Schwarz, E. Pohanka, G. Syre, Increased deposition of Indium-111-labeled platelets in chronically rejected kidney transplants, Clin Nephrol 18: 311 (1982).PubMedGoogle Scholar
  39. 39.
    R. Ross, J. Glomset, B. Kariya, L. Harker, A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro, Proc Natl Acad Sci USA 71: 1207 (1974).PubMedCrossRefGoogle Scholar
  40. 40.
    J. F. Mowbray, and A. Pariyananda, Platelet thrombi in rejection of renal allografts, in: “Immunological Mechanisms in Blood Coagulation, Thrombosis and Haemostasis,” R. Duckert, K. M. Brinktous, S. Hinnom, eds. Schattauer Verlag, Stuttgart (1971).Google Scholar
  41. 41.
    International Committee for Standardization in Hematology, Recommended methods for radioisotope platelet survival studies, Blood 50: 1137 (1977).Google Scholar
  42. 42.
    M. L. Thakur, M. J. Welch. J. H. Joist, R. E. Colemna, Indium-111-labeled platelets: studies on preparation and evaluation of in vitro and in vivo functions, Thromb Res 9: 345 (1976).PubMedCrossRefGoogle Scholar
  43. 43.
    M. L. Thakur, L. Walsh, H. L. Malech, A. Gottschalk, Indium-111-labled human platelets-improved method, efficacy, and evaluation, J Nucl Med 22: 381 (1981).PubMedGoogle Scholar
  44. 44.
    U. Scheffel, M. F. Tsan, T. G. Mitchell, E. E. Camargo, H. Braine, M. D. Ezekowitz, E. L. Nickoloff, R. Hillzobel, E. Murphy, P. A. Mclntryer, Human platelets labeled with In-111 8-hydroxy-quinoline-kinetics, distribution, and estimates of radiation dose, J Nucl Med 23: 149 (1982).PubMedGoogle Scholar
  45. 45.
    O. R. Van Reenen, Radiation dose from human platelets labeled with Indium-111, Br J Radiol 54: 1011 (1981).PubMedCrossRefGoogle Scholar
  46. 46.
    O. R. Van Reenen, M. G. Lotter, A. Du, P. Heyns, F. De Kock, C. Herbst, H. Kotze, H. Pieters, P.C. Minnaar, P. N. Badenhorst, Quantification of the distribution of In-111-labeled platelets in organs, Eur J Nucl Med 7: 80 (1982).PubMedCrossRefGoogle Scholar
  47. 47.
    H. H. Davis, W. A. Heaton, B. A. Siegel, C. J. Mathias, J. H. Joist, L. A. Sherman, M. J. Welch, Scintigraphic detection of atherosclerotic lesions and venous thrombi in man by Indium-111-labeled autologous platelets, Lancet 1: 1185 (1978).PubMedCrossRefGoogle Scholar
  48. 48.
    A. Fenech, J. K. Hussey, F. W. Smith, P. P. Dendy, B. Bennett, A. S. Douglas, Diagnosis of deep vein thrombosis using autologous Indium-111-labeled platelets, Br J Med 282: 1020 (1981).CrossRefGoogle Scholar
  49. 49.
    R. L. Lantieri, D. A. Goodwin, D. Guthaner, F. Conley, M. L. Goris, P. W. Doherry, Static and dynamic studies of deep veinous thrombosis and atherosclerosis in humans with Indium-111-labeled platelets, Br J Radiol 53: 9222 (1980).Google Scholar
  50. 50.
    J. H. Joist, and R. K. Baker, Loss of In-111 as indicator of platelet injury, Blood 58: 350 (1981).PubMedGoogle Scholar
  51. 51.
    K. A. Peterson, M. K. Dewanjee, M. P. Kaye, Fate of Indium111-labeled platelets during cardiopulmonary bypass performed with membrane and bubble oxygenaors, J Thorac Cardiovasc Surg 84: 39 (1982).PubMedGoogle Scholar
  52. 52.
    J. L. Ritchie, J. R. Stratton, B. Thiele, G. W. Hamilton, L. N. Warrick, T. W. Huang, L. A. Harker, Indium-111 platelet imaging for detection of platelet deposition in abdominal aneurysms and prostetic arterial grafts, Am J Cardiol 47: 882 (1981).PubMedCrossRefGoogle Scholar
  53. 53.
    N. Smith, S. Chandler, R. J. Hawker, L. M. Hawker, A. D. Barnes, Indium-labelled autologous platelets as diagnostic aid after renal transplantation, Lancet 11: 1241 (1979).CrossRefGoogle Scholar
  54. 54.
    J. A. C. Buckels, S. Chandler, R. Hawker, A. D. Barnes, L. N. McCollum, The early diagnosis of acute renal transplant rejection using In-133-labeled platelets, Br J Surg 69: 285 (1982).Google Scholar
  55. 55.
    J. A. Buckles, S. Chandler, R. Hawker, C. N. McCollum, A. D. Barnes, The early diagnosis of acute renal transplant rejection using Indium-111-labeled platelets, Transplant Proc 15: 1192 (1983).Google Scholar
  56. 56.
    J. Chandler, J. Buckles, R. Hawker, N. Smith, A. D. Barnes, C. N. McCollum, Does platelet deposition predict renal transplant failure due to rejection? Br J Surg 68: 801 (1981).CrossRefGoogle Scholar
  57. 57.
    A. Fenech, A. Nicholls, F. W. Smith, Indium-111-labeled platelets in the diagnosis of renal transplant rejection: preliminary findings, Br J Radiol 54: 325 (1981).PubMedCrossRefGoogle Scholar
  58. 58.
    J. M. Grino, J. Alsina, J. Martin, M. Roca, A. Castelao, R. Romero, A. Caralps, Indium-111-labeled autologous platelets as a diagnostic method in kidney allograft rejection, Transplant Proc 14: 198 (1982).Google Scholar
  59. 59.
    M. R. Hardeman, J. B. Vanderschoot, J. Vreeken, The early diagnosis of kidney graft rejection with Indium-111oxine-labeled thrombocytes, Br J Radiol 53: 923 (1980).Google Scholar
  60. 60.
    A. J. W. Hilson, C. Lazarus, A. Parbtani, J. S. Cameron, M. N. Maisey Indium-111 platelets in early detection of kidney graft rejection in: “Radionuclides in Nephrology,” A. M. Joekes, A. R. Constable, N. J. G. Brown, W. N. Taoxe, eds. Academic Press, London (1982).Google Scholar
  61. 61.
    J. H. Ten Veen, E. A. Van Royen, S. Surachno, J. B. Van der Schoot, M. Hardeman, J. Vreeken, J. M. Silmink, Diagnostic use of Indium-111-labeled platelets in kidney transplant rejection, 8th Int.Congr. of Nephrol., Athens (abstr.) (1981).Google Scholar
  62. 62.
    A. Fenech, B. Bennet, G. R. D. Catto, N. Edwards, A. S. Douglas, F. W. Smith, P. F. Sharp, D. Parry-Jones, Diagnosis of post-transplant renal haematoma with autologous Indium-111-labeled plateletes, Lancet 1: 1250 (1980).PubMedCrossRefGoogle Scholar
  63. 63.
    G. J. Busch, A. C. P. Martins, N. K. Hollenberg, R. C. Moretz, R. E. Wilson, R. W. Colman Successful short-term modification of hyperacute renal allograft rejection in the primate. Intrarenal effects of phenoxybenzamine and methylprednisolone combined with heparin, Am J Pathol 82: 43 (1976).PubMedGoogle Scholar
  64. 64.
    P. Belitsky, M. Popovtzer, J. Corman, B. Launois, K. A. Porter, Modification of hyperacute xenograft rejection by intra-arterial infusion of disodium ethylenediaminetetraacetate, Transplantation 15: 248 (1973).PubMedCrossRefGoogle Scholar
  65. 65.
    T. H. Mathew, P. Kincaid-Smith, D. H. Clyne, B. M. Saker, R. S. Nanra, P. J. Morris, V. C. Marshell, A controlled trial or oral anticoagulants and dipyridamole in cadaveric renal allografts, Lancet 1: 1307 (1974).PubMedCrossRefGoogle Scholar
  66. 66.
    H. M. Kauffman, M. B. Adams, L. A. Herbert, P. M. Walczak, Platelet inhibitors in human renal homotransplantation; randomized comparision of aspirin versus dipyridamole, Transplant Proc 12: 311 (1980).PubMedGoogle Scholar
  67. 67.
    C. B. Anderson, B. M. Jaffe, R. J. Graff, Prolongation of murine skin allografts by prostaglandin El, Transplantation 23: 44–447 (1977).CrossRefGoogle Scholar
  68. 68.
    S. Moncada, R. Gryglewski, S. Bunting, J. R. Vane, An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation, Nature 263: 663 (1976).PubMedCrossRefGoogle Scholar
  69. 69.
    S. Moncada, E. A. Higgs, J. R. Vane Human arterial and venous tissues generate prostacyclin (prostaglandin X), a potent inhibitor of platelet aggregation, Lancet 1: 18 (1977).PubMedCrossRefGoogle Scholar
  70. 70.
    R. A. Johnson, F. H. Lincoln, J. L. Thompson, E. G. Nidy, S. A. Mizsak, U. Axen, Synthesis and stereochemistry of prostacyclin and synthesis of 6-ketoprostaglandidn F12, J Am Chem Soc 99: 4182 (1977).PubMedCrossRefGoogle Scholar
  71. 71.
    A. R. Mundy, Prolongation of cat to dog renal xenograft survival with prostacyclin, Transplantation 30: 226 (1980).PubMedGoogle Scholar
  72. 72.
    A. R. Mundy, M. Bewick, S. Moncada, J. R. Vane, Short term suppression of hyperacute renal allograft rejection in presensitised dogs with prostacyclin, Prostaglandins 19: 595 (1980).PubMedCrossRefGoogle Scholar
  73. 73.
    T. S. T. Wang, S. Oluwole, R. A. Fawwaz, M. Woff, N. Kuromoto, K. Satake, M. A. Hardy, P. O. Alderson, Cellular basis for accumulation of In-111-labeled leukocytes and platelets in rejecting cardiac allografts: concise communication, J Nucl Med 23: 998 (1982).Google Scholar
  74. 74.
    J. L. Ritchie, A. Lindner, G. W. Hamilton, L. A. Harker, Indium-111 platelet imaging for detection of platelet deposition in abdominal aneurysms and prosthetic arterial grafts, Am J Cardiol 47: 882 (1982).CrossRefGoogle Scholar
  75. 75.
    W. A. Jurewitz, J. G. A. Dykes, R. J. Hawker, S. T. Chandler, B. K. Gunson, A. D. Barnes, Tubular damage or rejection: bedside method for differential diagnosis in patients on cyclosporin, Lancet 1: 998 (1983).CrossRefGoogle Scholar
  76. 76.
    H. Sinzinger, P. Clopath, K. Siberbauer, M. Winter, Is the variation in the susceptibilty of various species to atherosclerosis due to inborn differences in prostacyclin (PGI2) formation, Experientia 36: 321 (1980).PubMedCrossRefGoogle Scholar
  77. 77.
    D. E. Maclntytre, J. D. Pearson, J. L. Gordon, Localisation and stimulation of prostacyclin production in vascular cells, Nature 271: 549 (1978).CrossRefGoogle Scholar
  78. 78.
    G. Remuzzi, D. Marchesi, G. Mecca, R. Misiani, M. Livio, G. DeGaetano, M. B. Donati, Uraemic syndrome: deficiency of plasma factor(s) regulating prostacyclin activity? Lancet 1: 871 (1978).CrossRefGoogle Scholar
  79. 79.
    J. M. Hows, P. M. Chipping, S. Fairhead, J. Smith, A. Baughan, E. C. Gordon-Smith, Nephrotoxicity in bone marrow transplant recipients treated with cyclosporin A, Br J Haematol 54: 69 (1983).PubMedCrossRefGoogle Scholar
  80. 80.
    H. Shulman, G. Striker, H. J. Deeg, M. Kennedy, R. Storb, E. D. Thomas, Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: glomerular thrombosis and tubular injury, New Engl J Med 305: 1392 (1981).PubMedCrossRefGoogle Scholar
  81. 81.
    G. Rocchi, L. Imberti, F. Fumagalli, G. Neild, G. Remutti Cyclosporin-A induces glomerula thrombosis possibly affecting vascular PGI2-production, V.Int.Conf. on Prostaglandins, Florence (abstr.), 759 (1982).Google Scholar
  82. 82.
    G. H. Neild and G. Rocchi, Effect of cyclosporine on prostacyclin synthesis by vascular tissue in rabbits, First International Congress on Cyclosporin (abstr.), Houston, Texas, (1983).Google Scholar
  83. 83.
    C. Leíthner, H. Sinzinger, E. Pohanka, M. Schwarz, G. Kretschmer, G. Syre, Recurrence of haemolytic uraemic syndrome triggered by cyclosporin A after renal transplantation, Lancet 1: 1470 (1982).PubMedCrossRefGoogle Scholar
  84. 84.
    D. V. Hamilton, R. Y. Caine, D. B. Evans, Haemolytic-uraemic syndrome and cyclosporin A, Lancet 1: 151 (1982).CrossRefGoogle Scholar
  85. 85.
    D. V. Hamilton, D. J. S. Carmichael, D. B. Evans, R. Y. Caine, Hypertension in renal transplant recipients on cyclosporin A and corticosteroids and azathioprine, Transpl Proc 14: 497 (1982).Google Scholar
  86. 86.
    M. L. Foegh, M. Zmudka, C. Cooley, J. F. Winchester, G. B. Helfrich, P. W. Ramwell, G. E. Schreiner, Urine i-TXB2 in renal allograft rejection, Lancet 11: 431 (1981).CrossRefGoogle Scholar
  87. 87.
    M. L. Foegh, J. F. Winchester, M. Zmudka, G. B. Helfrich, P. W. Ramwell, G. E. Schreiner, Aspirin inhibition of thromboxane release in thrombosis and renal transplant rejection, Lancet 1: 48 (1982).PubMedCrossRefGoogle Scholar
  88. 88.
    A. Capítanio, P. M. Mannucci, C. Ponticelli, F. Pareti, Detection of circulating released platelets after renal transplantion, Transplantation 33: 298 (1982).PubMedCrossRefGoogle Scholar
  89. 89.
    A. D. Heyns, M. G. Lotter, H. Pieters, F. H. Pauw, P. N. Badenhorst, P. Wessels, P. C. Minnaar, A quantitative study of Indium-111-oxine platelet kinetics in acute and chronic renal transplant, Clin Nephrol 18: 174 (1982).PubMedGoogle Scholar
  90. 90.
    P. Ghosh, D. B. Evans, S. A. Tomlinson, R. Y. Caine, Plasma lipids following renal transplantation, Transplantation 15: 521 (1973).PubMedCrossRefGoogle Scholar
  91. 91.
    S. J. Shattil, R. Anaya-Galindo, J. Bennett, R. W. Colman, R. A. Cooper, Platelet hypersensitivity induced by cholesterol incorporation, J Clin Invest 55: 636 (1975).PubMedCrossRefGoogle Scholar
  92. 92.
    A. Szczeklik and R. J. Gryglewski, Low density lipoprotiens (LDL) are carriers for lipid peroxides and inhibit prostacyclin (PGI2) biosynthesis in arteries, Artery 7: 488 (1980).PubMedGoogle Scholar
  93. 93.
    A. J. K. Laden, Experimental atherosclerosis in rat and rabbit cardiac allografts, Arch Path 93: 240 (1972).PubMedGoogle Scholar
  94. 94.
    D. R. Alonso, P. K. Starek, C. R. Minick, Studies on the pathogenesis of atheroarteriosclerosis induced in rabbit cardiac allografts by synergy of graft rejection and hypercholesterolemia, Am J Pathol 87: 415 (1977).PubMedGoogle Scholar
  95. 95.
    K. Silberbauer, G. Schernthaner, H. Sinzinger, H. Piza-Katzer, M. Winter, Decreased vascular prostacyclin in juvenile-onset diabetes, New Engl J Med 300: 366 (1979).PubMedGoogle Scholar
  96. 96.
    H. Sinzinger and A. Kefalides, Passive smoking severely decreases platelet sensitivity to anti-aggregatory prostaglandins, Lancet 11: 392 (1982).CrossRefGoogle Scholar
  97. 97.
    S. R. Coughlin, M. A. Moskowitz, B. R. Zetter, H. N. Antoniades, L. Levine, Platelet-dependent stimulation of prostacyclin synthesis by platelet-derived growth factor, Nature 288: 600 (1980).PubMedCrossRefGoogle Scholar
  98. 98.
    J. G. Gerber, A. S. Nies, G. C. Friesinger, J. F. Gerkens, R. A. Branch, J. A. Oates, The effect of PGI2 on canine renal function and hemodynamics, Prostaglandins 16: 519 (1978).PubMedCrossRefGoogle Scholar
  99. 99.
    J. A. Oates, A. R. Whorton, J. Gerber, J. Lazar, R. A. Branch, J. W. Hollifield, Prostacyclin and the kidney, in: “Prostacyclin,” J.R. Vane and S. Bergström, eds., Raven Press, New York (1979).Google Scholar
  100. 100.
    T. Niwa, K. Maeda, H. Asada, M. Yamamoto, K. Yamada, Beneficial effect of prostaglandine El in rapidly progressive glomerulonephritis., New Engl J Med 308: 969 (1983).PubMedGoogle Scholar
  101. 101.
    M. M. Popovtzer, W. Pinggera, F. H. Katz, J. L. Corman, J. Robinette, B. Lanois, C. G. Halgrimson, T. Starzl, in arterial blood pressure after kidney transplantation. Relation to renal function, plasma renin activity and the dose of prednisone, Circulation 4: 1297 (1973).Google Scholar
  102. 102.
    J. R. Weeks and D. M. Sutter, An antihypertensive effect of prostacyclin, in: “Prostacyclin,” J.R. Vane and S. Bergström, eds., Raven Press, New York (1979).Google Scholar
  103. 103.
    R. R. Lindquist, R. D. Guttmann, J. P. Merrill, G. J. Dammin, Human renal allografts. Interpretation of morphologic and immuno-histo-chemical observations, Am J Path 53: 851 (1968).PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • Helmut F. Sinzinger
    • 1
  • Christian W. Leithner
    • 2
  1. 1.Division of Nuclear MedicineUniversity of ViennaViennaAustria
  2. 2.Second Department of Internal MedicineUniversity of ViennaViennaAustria

Personalised recommendations